ATE361075T1 - Pharmazeutische kombination zur behandlung von benigner prostatahyperplasie oder zur langzeitvorbeugung von akuter harnzurückhaltung - Google Patents
Pharmazeutische kombination zur behandlung von benigner prostatahyperplasie oder zur langzeitvorbeugung von akuter harnzurückhaltungInfo
- Publication number
- ATE361075T1 ATE361075T1 AT03725053T AT03725053T ATE361075T1 AT E361075 T1 ATE361075 T1 AT E361075T1 AT 03725053 T AT03725053 T AT 03725053T AT 03725053 T AT03725053 T AT 03725053T AT E361075 T1 ATE361075 T1 AT E361075T1
- Authority
- AT
- Austria
- Prior art keywords
- long
- pharmaceutical combination
- benigan
- treatment
- urinary retention
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/18—Sulfonamides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/28—Antiandrogens
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Diabetes (AREA)
- Endocrinology (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE2002118392 DE10218392A1 (de) | 2002-04-24 | 2002-04-24 | Verwendung von Arzneimittelkombinationen zur Behandlung von benigner Prostatahyperplasie |
DE2002118611 DE10218611A1 (de) | 2002-04-25 | 2002-04-25 | Verwendung einer Tamsulosin enthaltenden Arzneimittelkombination zur Behandlung von benigner Prostatahyperplasie |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE361075T1 true ATE361075T1 (de) | 2007-05-15 |
Family
ID=29271571
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT03725053T ATE361075T1 (de) | 2002-04-24 | 2003-04-17 | Pharmazeutische kombination zur behandlung von benigner prostatahyperplasie oder zur langzeitvorbeugung von akuter harnzurückhaltung |
Country Status (22)
Country | Link |
---|---|
US (2) | US20030225118A1 (de) |
EP (2) | EP1501517B1 (de) |
JP (1) | JP2005524693A (de) |
CN (1) | CN1646135A (de) |
AT (1) | ATE361075T1 (de) |
AU (1) | AU2003227643A1 (de) |
BR (1) | BR0309435A (de) |
CA (1) | CA2479992A1 (de) |
CY (1) | CY1107674T1 (de) |
DE (1) | DE60313603T2 (de) |
DK (1) | DK1501517T3 (de) |
EA (1) | EA008377B1 (de) |
ES (1) | ES2287474T3 (de) |
HR (1) | HRP20040994A2 (de) |
IL (1) | IL163976A0 (de) |
MX (1) | MXPA04010408A (de) |
NO (1) | NO20044333L (de) |
NZ (1) | NZ536514A (de) |
PL (1) | PL371430A1 (de) |
PT (1) | PT1501517E (de) |
RS (1) | RS92304A (de) |
WO (1) | WO2003090753A1 (de) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1646135A (zh) * | 2002-04-24 | 2005-07-27 | 贝林格尔英格海姆法玛两合公司 | 治疗良性***增生或长期预防急性尿潴留的药物组合 |
KR20060124603A (ko) * | 2003-11-03 | 2006-12-05 | 베링거 인겔하임 인터내셔날 게엠베하 | 베타-3-아드레날린 수용체 효능제 및 알파 길항제 및/또는5-알파-리덕타제 억제제를 함유하는 약제학적 조성물 |
CN101452893B (zh) * | 2003-11-14 | 2011-04-13 | 株式会社半导体能源研究所 | 显示装置及其制造法 |
WO2006055659A2 (en) * | 2004-11-15 | 2006-05-26 | Smithkline Beecham Corporation | Fixed dose combination op dutasteride and tamsulosin |
CN102309495A (zh) * | 2010-06-30 | 2012-01-11 | 北京润德康医药技术有限公司 | 一种复方制剂及其制备方法 |
WO2012110092A1 (en) | 2011-02-17 | 2012-08-23 | Synthon Bv | Tamsulosin derivatives |
BRPI1103204A2 (pt) * | 2011-06-03 | 2014-02-25 | Eurofarma Lab S A | Composição farmacêutica para o tratamento de hiperplasia prostática benigna |
WO2013123965A1 (en) | 2012-02-20 | 2013-08-29 | Synthon Bv | A fixed dose pharmaceutical formulation |
US10596127B2 (en) | 2013-03-14 | 2020-03-24 | Wellesley Pharmaceuticals, Llc | Composition for reducing the frequency of urination, method of making and use thereof |
BR102013020508B1 (pt) * | 2013-08-12 | 2021-01-12 | Ems S/A. | Forma de dosagem que compreende um inibidor de esteroide 5-alfa-redutase e um bloqueador alfa, processo para a preparaçãode uma forma de dosagem e uso da forma de dosagem |
EP2949319A1 (de) | 2014-05-26 | 2015-12-02 | Galenicum Health S.L. | Pharmazeutische zusammensetzungen mit einem wirkstoff |
SG11201805527QA (en) * | 2015-09-30 | 2018-07-30 | Wellesley Pharmaceuticals Llc | Composition for reducing the frequency of urination, method of making and use thereof |
US10172910B2 (en) * | 2016-07-28 | 2019-01-08 | Nymox Corporation | Method of preventing or reducing the incidence of acute urinary retention |
CN115969860A (zh) * | 2021-10-14 | 2023-04-18 | 上海汇伦医药股份有限公司 | 一种药物组合物及其用途 |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5391825A (en) * | 1980-02-08 | 1995-02-21 | Yamanouchi Pharmaceutical Co., Ltd. | Sulfamoyl substituted phenethylamine intermediates |
JPS56110665A (en) | 1980-02-08 | 1981-09-01 | Yamanouchi Pharmaceut Co Ltd | Sulfamoyl-substituted phenetylamine derivative and its preparation |
US4760071A (en) | 1984-02-27 | 1988-07-26 | Merck & Co., Inc. | 17β-N-monosubstituted carbamoyl-4-aza-5α-androst-1-en-3-ones which are active as testosterone 5α-reductase inhibitors |
NZ211145A (en) | 1984-02-27 | 1988-10-28 | Merck & Co Inc | 4-aza-5-alpha-androst-1-en-3-ones and pharmaceutical compositions |
US4772475A (en) | 1985-03-08 | 1988-09-20 | Yamanouchi Pharmaceutical Co., Ltd. | Controlled-release multiple units pharmaceutical formulation |
EP0285382B1 (de) | 1987-04-03 | 1994-04-13 | Merck & Co. Inc. | Behandlung von androgener Alopecia mit 17-bêta-n-mono-substituierten-carbamoyl-4-aza-5-alpha-androst-1-en-3-onen |
DE3888378T2 (de) | 1987-04-03 | 1994-09-29 | Merck & Co Inc | Behandlung von Prostatacarcinoma mit 17-beta-n-monosubstituierten-Carbamoyl-4-aza-5-alpha-Androst-1-en-3-onen. |
NZ241979A (en) * | 1991-03-20 | 1996-01-26 | Merck & Co Inc | Treatment of benign prostatic hyperplasia using 5alpha-reductase inhibitor and an alpha1-adrenergic recepter blocker |
TW369521B (en) * | 1993-09-17 | 1999-09-11 | Smithkline Beecham Corp | Androstenone derivative |
TW382595B (en) | 1993-10-15 | 2000-02-21 | Merck & Co Inc | Pharmaceutical composition for use in arresting and reversing androgenic alopecia |
US6423719B1 (en) * | 1999-02-16 | 2002-07-23 | Upsher-Smith Laboratories, Inc. | Method for treating benign prostate hyperplasia |
AU7703700A (en) * | 1999-09-22 | 2001-04-24 | Merck & Co., Inc. | Treatment of lower urinary tract symptoms and pharmaceutical compositions for use therein |
CN1646135A (zh) * | 2002-04-24 | 2005-07-27 | 贝林格尔英格海姆法玛两合公司 | 治疗良性***增生或长期预防急性尿潴留的药物组合 |
-
2003
- 2003-04-17 CN CNA038089300A patent/CN1646135A/zh active Pending
- 2003-04-17 AT AT03725053T patent/ATE361075T1/de active
- 2003-04-17 CA CA002479992A patent/CA2479992A1/en not_active Abandoned
- 2003-04-17 NZ NZ536514A patent/NZ536514A/en unknown
- 2003-04-17 JP JP2003587387A patent/JP2005524693A/ja active Pending
- 2003-04-17 EP EP03725053A patent/EP1501517B1/de not_active Revoked
- 2003-04-17 PT PT03725053T patent/PT1501517E/pt unknown
- 2003-04-17 WO PCT/EP2003/004034 patent/WO2003090753A1/en active IP Right Grant
- 2003-04-17 PL PL03371430A patent/PL371430A1/xx not_active Application Discontinuation
- 2003-04-17 AU AU2003227643A patent/AU2003227643A1/en not_active Abandoned
- 2003-04-17 RS YU92304A patent/RS92304A/sr unknown
- 2003-04-17 DE DE60313603T patent/DE60313603T2/de not_active Revoked
- 2003-04-17 BR BR0309435-9A patent/BR0309435A/pt not_active Expired - Fee Related
- 2003-04-17 EA EA200401340A patent/EA008377B1/ru not_active IP Right Cessation
- 2003-04-17 MX MXPA04010408A patent/MXPA04010408A/es active IP Right Grant
- 2003-04-17 IL IL16397603A patent/IL163976A0/xx unknown
- 2003-04-17 ES ES03725053T patent/ES2287474T3/es not_active Expired - Lifetime
- 2003-04-17 EP EP06122312A patent/EP1743656A3/de not_active Withdrawn
- 2003-04-17 DK DK03725053T patent/DK1501517T3/da active
- 2003-04-24 US US10/422,509 patent/US20030225118A1/en not_active Abandoned
-
2004
- 2004-10-12 NO NO20044333A patent/NO20044333L/no not_active Application Discontinuation
- 2004-10-22 HR HR20040994A patent/HRP20040994A2/hr not_active Application Discontinuation
-
2007
- 2007-04-06 US US11/697,470 patent/US20070197666A1/en not_active Abandoned
- 2007-06-14 CY CY20071100794T patent/CY1107674T1/el unknown
Also Published As
Publication number | Publication date |
---|---|
DE60313603T2 (de) | 2008-01-03 |
CN1646135A (zh) | 2005-07-27 |
CY1107674T1 (el) | 2013-04-18 |
NZ536514A (en) | 2006-11-30 |
EP1743656A2 (de) | 2007-01-17 |
JP2005524693A (ja) | 2005-08-18 |
IL163976A0 (en) | 2005-12-18 |
EP1501517A1 (de) | 2005-02-02 |
US20030225118A1 (en) | 2003-12-04 |
EA008377B1 (ru) | 2007-04-27 |
HRP20040994A2 (en) | 2005-02-28 |
WO2003090753A8 (en) | 2004-11-04 |
ES2287474T3 (es) | 2007-12-16 |
NO20044333L (no) | 2004-11-09 |
US20070197666A1 (en) | 2007-08-23 |
DK1501517T3 (da) | 2007-06-11 |
EP1743656A3 (de) | 2007-03-07 |
EA200401340A1 (ru) | 2005-06-30 |
PL371430A1 (en) | 2005-06-13 |
DE60313603D1 (de) | 2007-06-14 |
PT1501517E (pt) | 2007-05-31 |
AU2003227643A1 (en) | 2003-11-10 |
MXPA04010408A (es) | 2005-02-17 |
CA2479992A1 (en) | 2003-11-06 |
BR0309435A (pt) | 2005-02-15 |
WO2003090753A1 (en) | 2003-11-06 |
RS92304A (en) | 2006-10-27 |
EP1501517B1 (de) | 2007-05-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY1107674T1 (el) | Φαρμακευτικος συνδυασμος για τη θεραπευτικη αντιμετωπιση της καλοηθους υπερπλασιας του προστατη ή για την μακροπροθεσμη προληψη της οξειας επισχεσης ουρων | |
DE60023982D1 (de) | System zur Behandlung von benigner Prostatahyperplasie | |
ATE208210T1 (de) | Kombination von proteintyrosin-kinaseinhibitoren und chemischer kastration zur behandlung von prostatakrebs | |
DE69830072D1 (de) | Radioaktive zusammensetzungen zur behandlung von prostatatumoren | |
ATE242238T1 (de) | Chinolin- und chinazolin-verbindungen von therapeutischem nutzen, insbesondere zur behandlung von gutartiger prostatahyperplasie | |
DE60045751D1 (de) | Therapeutische Behandlung androgenrezeptorbedingter Leiden | |
NO20014560L (no) | Quinasoliner og terapautisk anvendelse derav | |
DK1373215T3 (da) | Gelanamycinderivater egnet til behandling af cancer | |
TR200102499T2 (tr) | Neoplazi tedavisinde bir kombinasyon terapisi olarak bir siklooksijenaz-2 inhibitörü ve bir veya daha fazla antineoplastik ajan kullanma yöntemi | |
PT971713E (pt) | Utilizacao de inibidores da colinesterase para tratamento de desordens da atencao | |
IL169685A0 (en) | Treatment of benign prostatic hyperplasia using energolytic agents | |
ATE281845T1 (de) | Kombinationstherapie enthaltend bestrahlung und einen cox-2 hemmer in der behandlung von neoplasie | |
ATE362374T1 (de) | Verfahren und zusammensetzungen zur prevention oder behandlung von krebs und von krebs assoziertem knochenverlust | |
DK0565296T3 (da) | Anvendelse af melatonin til fremstilling af et lægemiddel til behandling af godartet prostatahyperplasi | |
DE60214207D1 (de) | Nagellack enthaltend tazaroten und verwendung dessen zur behandlung und/oder zur prävention von psoriasis | |
ATE250580T1 (de) | Substituierte pyridino-arylpiperazine zur behandlung benigner prostatahyperplasie | |
EA200401100A1 (ru) | 1α-ФТОР-25-ГИДРОКСИ-16,23E-ДИЕН-26,27-БИСГОМО-20-ЭПИХОЛЕКАЛЬЦИФЕРОЛ И ЕГО ПРИМЕНЕНИЕ ДЛЯ ЛЕЧЕНИЯ | |
ATE302009T1 (de) | Ubichinon qn zur behandlung von migräneschmerzen | |
DE60334289D1 (de) | Dithiolopyrrolon-derivate zur behandlung von proliferativen störungen | |
GB0301016D0 (en) | Treatment of benign prostatic hyperplasia | |
TR199701613T1 (xx) | Selim prostatik hiperplasyan�n tedavisi i�in melatonin agonistleri. | |
SI1501517T1 (sl) | Farmacevtska kombinacija za zdravljenje benigne hiperplazije prostate ali za dolgotrajno preprečevanje akutne retencije urina | |
DE69807166D1 (de) | Prostata-spezifische Antigen Inhibitore | |
UA3401U (uk) | Спосіб хірургічного лікування гострої затримки сечі у хворих на доброякісну гіперплазію передміхурової залози, ускладнену уретерогідронефрозом | |
ATE314854T1 (de) | Mittel zur prävention und/oder behandlung einer gewebeveränderung mesenchymalen ursprungs |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification |
Ref document number: 1501517 Country of ref document: EP |